{"id":11644,"date":"2021-09-21T08:00:57","date_gmt":"2021-09-21T08:00:57","guid":{"rendered":"https:\/\/www.atryshealth.com\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/"},"modified":"2021-09-21T08:00:57","modified_gmt":"2021-09-21T08:00:57","slug":"epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer","status":"publish","type":"articulo","link":"https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/","title":{"rendered":"Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Mar%C3%ADn-Aguilera+M&amp;cauthor_id=24659820\">Mercedes Mar\u00edn-Aguilera<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24659820\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Codony-Servat+J&amp;cauthor_id=24659820\">Jordi Codony-Servat<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Reig+%C3%92&amp;cauthor_id=24659820\">\u00d2scar Reig<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Lozano+JJ&amp;cauthor_id=24659820\">Juan Jos\u00e9 Lozano<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fern%C3%A1ndez+PL&amp;cauthor_id=24659820\">Pedro Luis Fern\u00e1ndez<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Pereira+MV&amp;cauthor_id=24659820\">Mar\u00eda Ver\u00f3nica Pereira<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Jim%C3%A9nez+N&amp;cauthor_id=24659820\">Natalia Jim\u00e9nez<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Donovan+M&amp;cauthor_id=24659820\">Michael Donovan<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Puig+P&amp;cauthor_id=24659820\">Pere Puig<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Mengual+L&amp;cauthor_id=24659820\">Lourdes Mengual<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Bermudo+R&amp;cauthor_id=24659820\">Raquel Bermudo<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Font+A&amp;cauthor_id=24659820\">Albert Font<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Gallardo+E&amp;cauthor_id=24659820\">Enrique Gallardo<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ribal+MJ&amp;cauthor_id=24659820\">Mar\u00eda Jos\u00e9 Ribal<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Alcaraz+A&amp;cauthor_id=24659820\">Antonio Alcaraz<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Gasc%C3%B3n+P&amp;cauthor_id=24659820\">Pere Gasc\u00f3n<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Mellado+B&amp;cauthor_id=24659820\">Bego\u00f1a Mellado<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mercedes Mar\u00edn-Aguilera\u00a01,\u00a0Jordi Codony-Servat,\u00a0\u00d2scar Reig,\u00a0Juan Jos\u00e9 Lozano,\u00a0Pedro Luis Fern\u00e1ndez,\u00a0Mar\u00eda Ver\u00f3nica Pereira,\u00a0Natalia Jim\u00e9nez,\u00a0Michael Donovan,\u00a0Pere Puig,\u00a0Lourdes Mengual,\u00a0Raquel Bermudo,\u00a0Albert Font,\u00a0Enrique Gallardo,\u00a0Mar\u00eda Jos\u00e9 Ribal,\u00a0Antonio Alcaraz,\u00a0Pere Gasc\u00f3n,\u00a0Bego\u00f1a Mellado<\/p>\n","protected":false},"template":"","class_list":["post-11644","articulo","type-articulo","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer - Atrys Health<\/title>\n<meta name=\"description\" content=\"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer - Atrys Health\" \/>\n<meta property=\"og:description\" content=\"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Atrys Health\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1563\" \/>\n\t<meta property=\"og:image:height\" content=\"1014\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Atrys_Health\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/en\\\/articulo\\\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\\\/\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/en\\\/articulo\\\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\\\/\",\"name\":\"Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer - Atrys Health\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#website\"},\"datePublished\":\"2021-09-21T08:00:57+00:00\",\"description\":\"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/en\\\/articulo\\\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.atryshealth.com\\\/en\\\/articulo\\\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/en\\\/articulo\\\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.atryshealth.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Art\u00edculos y patentes\",\"item\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/\",\"name\":\"Atrys Health\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#organization\",\"name\":\"Atrys Health S.A.\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/atrys-logo-probar-web.png\",\"contentUrl\":\"https:\\\/\\\/www.atryshealth.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/atrys-logo-probar-web.png\",\"width\":1563,\"height\":1014,\"caption\":\"Atrys Health S.A.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/Atrys_Health\",\"https:\\\/\\\/es.linkedin.com\\\/company\\\/atrys-health\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCejhA_ghBXRG1xoe9HB9pEw\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer - Atrys Health","description":"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer - Atrys Health","og_description":"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.","og_url":"https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/","og_site_name":"Atrys Health","og_image":[{"width":1563,"height":1014,"url":"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@Atrys_Health","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/","url":"https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/","name":"Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer - Atrys Health","isPartOf":{"@id":"https:\/\/www.atryshealth.com\/es\/#website"},"datePublished":"2021-09-21T08:00:57+00:00","description":"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.","breadcrumb":{"@id":"https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.atryshealth.com\/en\/articulo\/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.atryshealth.com\/en\/"},{"@type":"ListItem","position":2,"name":"Art\u00edculos y patentes","item":"https:\/\/www.atryshealth.com\/es\/articulo\/"},{"@type":"ListItem","position":3,"name":"Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.atryshealth.com\/es\/#website","url":"https:\/\/www.atryshealth.com\/es\/","name":"Atrys Health","description":"","publisher":{"@id":"https:\/\/www.atryshealth.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.atryshealth.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.atryshealth.com\/es\/#organization","name":"Atrys Health S.A.","url":"https:\/\/www.atryshealth.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.atryshealth.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png","contentUrl":"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png","width":1563,"height":1014,"caption":"Atrys Health S.A."},"image":{"@id":"https:\/\/www.atryshealth.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Atrys_Health","https:\/\/es.linkedin.com\/company\/atrys-health","https:\/\/www.youtube.com\/channel\/UCejhA_ghBXRG1xoe9HB9pEw"]}]}},"_links":{"self":[{"href":"https:\/\/www.atryshealth.com\/en\/wp-json\/wp\/v2\/articulo\/11644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atryshealth.com\/en\/wp-json\/wp\/v2\/articulo"}],"about":[{"href":"https:\/\/www.atryshealth.com\/en\/wp-json\/wp\/v2\/types\/articulo"}],"wp:attachment":[{"href":"https:\/\/www.atryshealth.com\/en\/wp-json\/wp\/v2\/media?parent=11644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}